Advertisement
Skip to Content

Teleflex Inc TFX Stock Quote

| Rating as of

NYSE: TFX

Last close prices updated as of Jan 31, 2023, 12:26 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 241.04
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Investment Style Mid Blend
  • Day Range 240.55  –  242.28
  • Year Range 182.65  –  356.72
  • Market Cap 11.3532 Bil
  • Volume / Avg 41,959.0 /  396,869.2
  • Price / Sales 4.08
  • Price / Book 2.90
  • Forward Div Yield 0.58%
  • Trailing Div Yield 0.56%

Morningstar‘s Stock Analysis TFX

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Teleflex Continues To Remain Well Entrenched in the Hospital Supply and Device Market

Debbie S. Wang Senior Equity Analyst

Business Strategy and Outlook

| Debbie Wang |

Over the past decade, Teleflex has transformed from a diverse industrial, commercial, and healthcare company to one focused on single-use medical devices using the dual levers of acquisitions and divestitures. Despite the completion of this transformation, Teleflex is likely to remain a serial acquirer, generally targeting companies in the $50 million-$200 million range where it can expand international scale and increase target company relevancy with group purchasing organizations. The firm prioritizes the development and acquisition of relatively inexpensive products--under $1,000--that are unlikely to be targeted by the healthcare device middlemen for cost savings. As an example, one night's stay in a hospital can lead to billed expenses of over $10,000, with Teleflex’s products accounting for around $500, or 5% of the total hospital cost.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics TFX

Company Profile TFX

Business Description

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (25% of 2021 sales), interventional (15%), anesthesia (14%), surgical (13%), interventional urology (12%), original-equipment manufacturing (9%), and all other (12%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.

Contact
550 East Swedesford Road, Suite 400
Wayne, PA, 19087
Industry Medical Instruments & Supplies
Employees 14,000

Related Articles TFX

FAQs for Teleflex Inc Stock

Yes. TFX has a forward dividend yield of 0.58%. See TFX’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

TFX’s market cap is 11.35 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

TFX’s stock style is Mid Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

TFX’s price/sales is 4.08.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

TFX’s price/forward earnings is 16.69.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

TFX’s price/book is 2.90.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See TFX’s valuation ratios compared to the Market Index.

TFX’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare TFX’s historical performance against its industry peers and the overall market.